Jpmorgan Chase & CO KARYOPHARM THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
38,000
Previous 38,000 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
N/A
38,000 New
38,000 $0
Q2 2022

Aug 11, 2022
SELL
N/A
-2,640,000 Reduced 74.58%
900,000 $655,000
Q1 2022

May 11, 2022
SELL
N/A
-1,750,000 Reduced 33.08%
3,540,000 $2.91 Million
Q4 2021

Feb 10, 2022
BUY
N/A
2,000,000 Added 60.79%
5,290,000 $4.29 Million
Q3 2021

Nov 12, 2021
BUY
N/A
3,290,000 New
3,290,000 $2.47 Million
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email